Daniel P. Caley

1.2k total citations
10 papers, 817 citations indexed

About

Daniel P. Caley is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Daniel P. Caley has authored 10 papers receiving a total of 817 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Cancer Research and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Daniel P. Caley's work include Cancer-related molecular mechanisms research (4 papers), RNA modifications and cancer (3 papers) and Ubiquitin and proteasome pathways (2 papers). Daniel P. Caley is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), RNA modifications and cancer (3 papers) and Ubiquitin and proteasome pathways (2 papers). Daniel P. Caley collaborates with scholars based in United Kingdom, United States and Canada. Daniel P. Caley's co-authors include Ryan Pink, David Raul Francisco Carter, Laura A. Jacobs, Kate Wicks, David R. F. Carter, Priya Samuel, Susan A. Brooks, Daniel Trujillano, Davide Massa and Naresh Magan and has published in prestigious journals such as Journal of Biological Chemistry, Blood and PLoS ONE.

In The Last Decade

Daniel P. Caley

10 papers receiving 805 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Daniel P. Caley	617	427	103	89	85	10	817
Young‐Soo Kwon	1.2k 2.0×	199 0.5×	48 0.5×	68 0.8×	206 2.4×	16	1.3k
Lowell G. Sheflin	687 1.1×	94 0.2×	76 0.7×	57 0.6×	126 1.5×	34	875
Ηλίας Στρατικόπουλος	627 1.0×	111 0.3×	65 0.6×	55 0.6×	85 1.0×	14	854
Karin Klinga‐Levan	531 0.9×	241 0.6×	39 0.4×	41 0.5×	211 2.5×	54	768
Elena Alexandrova	455 0.7×	137 0.3×	49 0.5×	134 1.5×	114 1.3×	47	669
Long Zhao	424 0.7×	215 0.5×	91 0.9×	56 0.6×	25 0.3×	40	650
Rakhi Gupta	662 1.1×	92 0.2×	32 0.3×	87 1.0×	134 1.6×	25	871
Joke Allemeersch	388 0.6×	107 0.3×	43 0.4×	174 2.0×	114 1.3×	20	725
Marie Keaveney	704 1.1×	93 0.2×	42 0.4×	70 0.8×	212 2.5×	16	903
Laura Schramm	1.0k 1.7×	181 0.4×	38 0.4×	74 0.8×	107 1.3×	27	1.3k

Countries citing papers authored by Daniel P. Caley

Since Specialization

Citations

This map shows the geographic impact of Daniel P. Caley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel P. Caley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel P. Caley more than expected).

Fields of papers citing papers by Daniel P. Caley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel P. Caley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel P. Caley. The network helps show where Daniel P. Caley may publish in the future.

Co-authorship network of co-authors of Daniel P. Caley

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel P. Caley. A scholar is included among the top collaborators of Daniel P. Caley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel P. Caley. Daniel P. Caley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Deng, Changchun, Paolo F. Caimi, Umar Farooq, et al.. (2024). Phase I Study Results of UF-Kure19, a CAR-T Product Manufactured in Less Than 1 Day, in Patients with Relapsed/Refractory Non-Hodgkin's Lymphoma. Blood. 144(Supplement 1). 94–94. 1 indexed citations

Debrand, Emmanuel, Lyubomira Chakalova, Yanfeng Dai, et al.. (2019). An intergenic non-coding RNA promoter required for histone modifications in the human β-globin chromatin domain. PLoS ONE. 14(8). e0217532–e0217532. 3 indexed citations

Bañuelos, Carmen A., Iran Tavakoli, Amy H. Tien, et al.. (2016). Sintokamide A Is a Novel Antagonist of Androgen Receptor That Uniquely Binds Activation Function-1 in Its Amino-terminal Domain. Journal of Biological Chemistry. 291(42). 22231–22243. 49 indexed citations

Samuel, Priya, et al.. (2015). Over-expression of miR-31 or loss of KCNMA1 leads to increased cisplatin resistance in ovarian cancer cells. Tumor Biology. 37(2). 2565–2573. 66 indexed citations

Pink, Ryan, Priya Samuel, Davide Massa, et al.. (2015). The passenger strand, miR-21-3p, plays a role in mediating cisplatin resistance in ovarian cancer cells. Gynecologic Oncology. 137(1). 143–151. 166 indexed citations

Kato, Minoru, Carmen A. Bañuelos, Yusuke Imamura, et al.. (2015). Cotargeting Androgen Receptor Splice Variants and mTOR Signaling Pathway for the Treatment of Castration-Resistant Prostate Cancer. Clinical Cancer Research. 22(11). 2744–2754. 46 indexed citations

Pink, Ryan, et al.. (2011). Pseudogenes: Pseudo-functional or key regulators in health and disease?. RNA. 17(5). 792–798. 314 indexed citations

Abdel-Hadi, Ahmed, Daniel P. Caley, David R. F. Carter, & Naresh Magan. (2011). Control of Aflatoxin Production of Aspergillus flavus and Aspergillus parasiticus Using RNA Silencing Technology by Targeting aflD (nor-1) Gene. Toxins. 3(6). 647–659. 49 indexed citations

Pink, Ryan, Christopher H. Eskiw, Daniel P. Caley, & David R. F. Carter. (2010). Analysis of β-globin Chromatin Micro-Environment Using a Novel 3C Variant, 4Cv. PLoS ONE. 5(9). e13045–e13045. 3 indexed citations

10.

Caley, Daniel P., Ryan Pink, Daniel Trujillano, & David R. F. Carter. (2010). Long Noncoding RNAs, Chromatin, and Development. The Scientific World JOURNAL. 10. 90–102. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact